Maleimide constrained BAD BH3 domain peptides as BCL-xL Inhibitors: A versatile approach to rapidly identify sites compatible with peptide constraining. (2023)
Attributed to:
Integrated computational and synthetic tools to drive the discovery of orthosteric protein-protein interaction inhibitors
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bmcl.2023.129260
PubMed Identifier: 36997005
Publication URI: http://europepmc.org/abstract/MED/36997005
Type: Journal Article/Review
Volume: 87
Parent Publication: Bioorganic & medicinal chemistry letters
ISSN: 0960-894X